Dr Reddy’s Laboratories Ltd ADR
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $76,331,392 | $87,268,000 | $88,051,000 | $85,452,000 |
Gross Profit | 34,215,174 | 46,806,000 | 48,140,000 | 48,627,000 |
EBITDA | 8,758,174 | 19,560,000 | 24,308,000 | 24,642,000 |
EBIT | 3,095,421 | 14,509,000 | 19,257,000 | 19,877,000 |
Net Income | 2,235,244 | 12,098,000 | 14,372,000 | 14,178,000 |
Net Change In Cash | 76,331,392 | 87,268,000 | 88,051,000 | 85,452,000 |
Free Cash Flow | 10,748,982 | 3,588,000 | 5,438,000 | 4,482,000 |
Cash | 15,063,755 | 18,657,000 | 9,906,000 | 9,004,000 |
Basic Shares | 834,805 | 833,196 | 833,020 | 833,020 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $353,471,642 | $325,535,000 | $279,164,000 | $245,879,000 |
Gross Profit | 186,518,732 | 190,428,000 | 163,607,000 | 139,343,000 |
EBITDA | 83,293,896 | 96,671,000 | 88,422,000 | 74,431,000 |
EBIT | 61,612,083 | 79,613,000 | 73,581,000 | 61,795,000 |
Net Income | 45,087,145 | 56,544,000 | 55,684,000 | 45,067,000 |
Net Change In Cash | 353,471,642 | 325,535,000 | 279,164,000 | 245,879,000 |
Free Cash Flow | 32,101,837 | 12,030,000 | 17,998,000 | 40,009,000 |
Cash | 15,063,755 | 14,654,000 | 7,107,000 | 5,779,000 |
Basic Shares | 833,263 | 834,298 | 833,537 | 831,912 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.16 |
2025-09-30 | $0.19 |
2025-06-30 | $17.02 |